Valuation: Makers Laboratories Limited

Market Cap 921M 9.63M 8.32M 7.82M 7.11M 13.37M 13.59M 91.6M 35.81M 461M 36.16M 35.38M 1.53B P/E 2025
10.2x
P/E 2026 33.9x
Enterprise Value 865M 9.04M 7.81M 7.34M 6.67M 12.55M 12.75M 85.98M 33.62M 433M 33.95M 33.21M 1.44B EV / Sales 2025
0.67x
EV / Sales 2026 0.53x
Free-Float
31.45%
Yield 2025 *
-
Yield 2026 -
1 day+1.89%
1 week-1.79%
Current month+4.73%
1 month+1.69%
3 months-0.10%
6 months+14.19%
Current year+32.12%
1 week 150.25
Extreme 150.25
167
1 month 146.2
Extreme 146.2
179.4
Current year 112.1
Extreme 112.1
186.7
1 year 109
Extreme 109
186.7
3 years 98.05
Extreme 98.05
230
5 years 94
Extreme 94
235
10 years 23.2
Extreme 23.2
344.8
Manager TitleAgeSince
Chief Executive Officer 51 11/08/2011
Director of Finance/CFO 59 30/10/2017
Compliance Officer - 23/05/2024
Director TitleAgeSince
Director/Board Member 51 11/08/2011
Director/Board Member 52 29/01/2018
Chairman 77 28/03/2019
Change 5-day change 1-year change 3-year change Capi.($)
+1.89%-1.79%+2.03%+41.46% 9.63M
-0.10%-0.77%+17.58%+70.16% 48.43B
-3.26%-5.31%+53.19%+117.23% 39.72B
-0.60%-0.94%-7.29%+17.35% 12.25B
-2.75%+1.88%+14.81%+76.92% 11.84B
-0.19%-0.38%+30.40%+135.91% 9.06B
+1.56%+5.52%+23.46%+39.78% 7.57B
+0.52%+2.08%+40.75%-12.45% 7.18B
-0.07%+1.72%+13.39%+190.65% 6.84B
-2.51%-3.14%-27.46%+24.20% 5.77B
Average -0.55%+0.59%+16.09%+70.12% 14.87B
Weighted average by Cap. -1.18%+1.03%+25.08%+81.16%

Financials

2025 2026
Net sales 1.21B 12.63M 10.91M 10.25M 9.32M 17.52M 17.81M 120M 46.95M 605M 47.41M 46.38M 2.01B 1.41B 14.73M 12.72M 11.96M 10.87M 20.44M 20.78M 140M 54.78M 705M 55.31M 54.11M 2.34B
Net income 74.91M 783K 677K 636K 578K 1.09M 1.11M 7.45M 2.91M 37.51M 2.94M 2.88M 125M 23.51M 246K 212K 200K 181K 341K 347K 2.34M 914K 11.77M 923K 903K 39.13M
Net Debt 48.19M 504K 435K 409K 372K 699K 711K 4.79M 1.87M 24.13M 1.89M 1.85M 80.2M -56.5M -591K -510K -480K -436K -820K -833K -5.62M -2.2M -28.29M -2.22M -2.17M -94.02M
Logo Makers Laboratories Limited
Makers Laboratories Limited is an integrated pharmaceutical company manufacturing and marketing around 200 formulations. The Company's segments include Pharmaceutical and Chemical Manufacturing. It has one manufacturing unit in India manufacturing formulations for the Indian market. Its product portfolio covers a range of general health therapeutic segments. Its formulation brands are Duramol (Paracetamol), Artemak-AB, Loroquin (Chloroquine), Nimuwin (Nimesulide), Coffwin (Anti-Cough range) and Exylin (Amoxycillin range). It also offers a range of diabetic and hypertensive drugs, including Voglibose, Gli-me range (Glimepiride + Metformin +Pioglitazone), and Hypernorm range (Telmisartan). Its product categories include Inspira - Retail Packs and Experia - Bulk Packs. Its Inspira - Retail Packs include anthelmintics, anti-biotics, anti-emetics and anti-nauseants. Its Experia - Bulk Packs include betamethasone 0.5 mg tablets, chloramphenicol capsules 250 mg and diclofenac 50 mg tablets.
Employees
114
Date Price Change Volume
14/08/26 INR 156.10 +1.89% 17,178
13/08/26 INR 153.20 -2.20% 3,586
12/08/26 INR 156.65 -2.12% 10,874
11/08/26 INR 160.05 +0.76% 2,480
10/08/26 INR 158.85 -0.06% 9,157
  1. Stock Market
  2. Stocks
  3. MAKERSL6 Stock